# Program 1 Phase C131 - Acknowledgment Write Permission Final No-Go

Status: final permission no-go

## Decision

No acknowledgment write permission may be seeded or referenced as a runtime permission in Phase C.

## Forbidden Permissions

The following permissions remain absent:

- `clinical_readiness.acknowledgments.write`
- `clinical_readiness.acknowledgments.manage`
- any API key acknowledgment write scope
- any AI agent acknowledgment write scope
- any system job acknowledgment write scope

## Why This Matters

Adding a write permission before a write endpoint decision would imply runtime readiness and create pressure to expose UI or API write actions.

That would weaken the no-go boundary and increase soft-clearance risk.

## Future Consideration

A physician-only write permission may be considered only in a separate future phase after:

- Findings Lifecycle Foundation exists
- write endpoint governance is approved
- audit and retention review is complete
- UI action semantics are reviewed
- real-data and production boundaries are explicitly decided

## Current Guard

Backend tests verify that acknowledgment write/manage permissions are not seeded.

## Conclusion

Acknowledgment write permission remains No-Go.

